These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22140394)

  • 1. Risk factors and incidence of hepatocellular carcinoma in Southeast Iran.
    Saiedi Hosseini SY
    Hepat Mon; 2011 Aug; 11(8):666-7. PubMed ID: 22140394
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of hepatocellular carcinoma in southeast iran.
    Moghaddam SD; Haghdoost AA; Hoseini SH; Ramazani R; Rezazadehkermani M
    Hepat Mon; 2010; 10(4):270-4. PubMed ID: 22312392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis.
    Hassanipour S; Mohammadzadeh M; Mansour-Ghanaei F; Fathalipour M; Joukar F; Salehiniya H; Abdzadeh E; Samadani AA; Nikbakht HA; Arab-Zozani M
    J Gastrointest Cancer; 2019 Jun; 50(2):193-200. PubMed ID: 30725358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces.
    Hajizadeh N; Baghestani AR; Pourhoseingholi MA; Ashtari S; Fazeli Z; Vahedi M; Zali MR
    World J Hepatol; 2017 May; 9(15):704-710. PubMed ID: 28596818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis.
    Pourhoseingholi MA; Fazeli Z; Zali MR; Alavian SM
    Asian Pac J Cancer Prev; 2010; 11(4):859-62. PubMed ID: 21133591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.
    Fattahi N; Rezaei N; Asadi-Lari M; Yousefi M; Madadi Z; Gohari K; Sheidaei A; Mohammadi E; Rezaei N; Parsaeian M; Kompani F; Farzadfar F
    PLoS One; 2021; 16(1):e0245468. PubMed ID: 33481849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.
    Zidan A; Scheuerlein H; Schüle S; Settmacher U; Rauchfuss F
    Hepat Mon; 2012 Oct; 12(10 HCC):e6894. PubMed ID: 23233864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for hepatocellular carcinoma in Southern Iran.
    Hajiani E; Masjedizadeh R; Hashemi J; Azmi M; Rajabi T
    Saudi Med J; 2005 Jun; 26(6):974-7. PubMed ID: 15983686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study.
    Karageorgos SA; Stratakou S; Koulentaki M; Voumvouraki A; Mantaka A; Samonakis D; Notas G; Kouroumalis EA
    Ann Gastroenterol; 2017; 30(3):357-363. PubMed ID: 28469367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.
    del Olmo JA; Serra MA; Rodríguez F; Escudero A; Gilabert S; Rodrigo JM
    J Cancer Res Clin Oncol; 1998; 124(10):560-4. PubMed ID: 9829860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiological study of Q fever in small ruminants from Southeast Iran.
    Ezatkhah M; Alimolaei M; Khalili M; Sharifi H
    J Infect Public Health; 2015; 8(2):170-6. PubMed ID: 25270385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma. An overview.
    Motola-Kuba D; Zamora-Valdés D; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2006; 5(1):16-24. PubMed ID: 16531960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.
    Yoshida H; Shiratori Y; Moriyama M; Arakawa Y; Ide T; Sata M; Inoue O; Yano M; Tanaka M; Fujiyama S; Nishiguchi S; Kuroki T; Imazeki F; Yokosuka O; Kinoyama S; Yamada G; Omata M
    Ann Intern Med; 1999 Aug; 131(3):174-81. PubMed ID: 10428733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: the changing epidemiology of hepatocellular carcinoma in Canada.
    Dyer Z; Peltekian K; van Zanten SV
    Aliment Pharmacol Ther; 2005 Jul; 22(1):17-22. PubMed ID: 15963075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
    Romano A; Angeli P; Piovesan S; Noventa F; Anastassopoulos G; Chemello L; Cavalletto L; Gambato M; Russo FP; Burra P; Vincenzi V; Scotton PG; Panese S; Tempesta D; Bertin T; Carrara M; Carlotto A; Capra F; Carolo G; Scroccaro G; Alberti A
    J Hepatol; 2018 Aug; 69(2):345-352. PubMed ID: 29551707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.
    Hosseini S; Dorgalaleh A; Bamedi T; Tavakol K; Tabibian S; Naderi M; Alizadeh S; Varmaghani B; Shamsizadeh M; Rahimizadeh A; Ebrahimi S
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):908-11. PubMed ID: 26226252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran.
    Naderi M; Reykande SE; Dorgalaleh A; Alizadeh S; Tabibian S; Einollahi N; Moghaddam EM
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):97-100. PubMed ID: 26703985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplant for Children With Hepatocellular Carcinoma and Hereditary Tyrosinemia Type 1.
    Bahador A; Dehghani SM; Geramizadeh B; Nikeghbalian S; Bahador M; Malekhosseini SA; Kazemi K; Salahi H
    Exp Clin Transplant; 2015 Aug; 13(4):329-32. PubMed ID: 24679101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on delta virus infection and its clinical impact in Iran.
    Rezvan H; Forouzandeh B; Taroyan S; Fadaiee S; Azordegan F
    Infection; 1990; 18(1):26-8. PubMed ID: 2155876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis.
    Gao X; Yang HI; Trinh H; Jeong D; Li J; Zhang J; Le A; Hoang J; Nguyen P; Henry L; Nguyen MH
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1207-1211. PubMed ID: 32129773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.